Hennion & Walsh Asset Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Sell |
109,149
-5,691
| -5% | -$611K | 0.47% | 31 |
|
|
2025
Q1 | $11.6M | Buy |
114,840
+7,500
| +7% | +$757K | 0.51% | 30 |
|
|
2024
Q4 | $9.59M | Buy |
107,340
+7,618
| +8% | +$680K | 0.43% | 38 |
|
|
2024
Q3 | $8.35M | Buy |
99,722
+15,769
| +19% | +$1.32M | 0.39% | 40 |
|
|
2024
Q2 | $6.47M | Buy |
83,953
+6,737
| +9% | +$519K | 0.33% | 53 |
|
|
2024
Q1 | $5.29M | Buy |
77,216
+10,532
| +16% | +$721K | 0.28% | 69 |
|
|
2023
Q4 | $3.86M | Buy |
66,684
+14,924
| +29% | +$863K | 0.22% | 112 |
|
|
2023
Q3 | $2.73M | Buy |
51,760
+20,079
| +63% | +$1.06M | 0.17% | 156 |
|
|
2023
Q2 | $1.71M | Buy |
31,681
+15,350
| +94% | +$830K | 0.1% | 241 |
|
|
2023
Q1 | $817K | Buy |
16,331
+11,279
| +223% | +$564K | 0.05% | 403 |
|
|
2022
Q4 | $234K | Sell |
5,052
-197
| -4% | -$9.13K | 0.01% | 701 |
|
|
2022
Q3 | $203K | Buy |
+5,249
| New | +$203K | 0.01% | 715 |
|